|
|
|
Salvage therapy in invasive pulmonary aspergillosis in an immunocompetent host
Saeid Fallah Tafti1, Bahareh Mokri2, Nahal Mansoori3, Shirin Karimi4, Payam Tabarsi5, Davood Mansoori6
1MD, Associated Professor of Medicine, Department of Internal Medicine,
2MD, General Practitioner, Department of Internal Medicine,
3MD, General Practitioner, Department of Internal Medicine,
4MD, Assistant Professor of Medicine, Department of Pathology,
5MD, Assistant Professor of Medicine, Department of Infectious Disease, 6MD, Professor of Medicine, Department of Infectious Disease, National Research Institute of Tuberculosis and Lung Disease (NRITLD), Shaheed Beheshti University of Medical Sciences and Health Services
SUMMARY. The majority of cases of invasive pulmonary aspergillosis (IPA) are seen in immunocompromised patients but IPA has been rarely reported in immunocompetent patients. The case is described of invasive pulmonary aspergillosis in an immunocompetent 17 year-old male, who was successfully treated with salvage therapy, including Itraconazole and Amphotericin B. Pneumon 2008; 21(1):77-80.
Key words: Aspergillosis, immunocompetence, treatment outcome.
Correspondence: Dr Saeid Fallah Tafti, Department of Internal Medicine, National Research Institute of Tuberculosis & Lung Disease, (Masih Daneshvari Hospital), Shahid Beheshti University of Medical Sciences and Health Services, Shaheed Bahonar Ave, Darabad, Tehran 19569, p.o.: 19575/154, Iran, Tel.: +98-21-20109502, Fax: +98-21-20109502; e-mail: saeid_ftafti@yahoo.com
 |